
Cost-Effectiveness of Cardioverter-Defibrillator Implantation in Kazakhstan
Author(s) -
Temirkhan Begisbayev,
Lyazzat Kosherbayeva,
Kamilla Gaitova,
Marzhan Brimzhanova
Publication year - 2022
Publication title -
vascular health and risk management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.892
H-Index - 68
eISSN - 1178-2048
pISSN - 1176-6344
DOI - 10.2147/vhrm.s369953
Subject(s) - medicine , per capita , implantable cardioverter defibrillator , cost effectiveness , quality adjusted life year , sudden cardiac death , cost effectiveness analysis , willingness to pay , actuarial science , emergency medicine , environmental health , risk analysis (engineering) , population , business , economics , microeconomics
Cardiovascular disease is the leading cause of morbidity and mortality worldwide. The implementation of effective technologies such as Implantable cardioverter-defibrillator (ICD) for patients at risk of sudden cardiac death requires additional health system resources.